Armata Pharmaceuticals, Inc. (ARMP) short interest & options flow
AMEXArmata Pharmaceuticals reports today against a rough backdrop: the stock has shed 21% over the past month and slipped another 2.6% on the week to $8.82, even as the broader small-cap biotech universe found its footing. Peers like CRBU and CBIO both gained more than 8% on the week — making ARMP's underperformance the clearest signal heading into the…
ARMP short interest dips 26.7% over one week to 0.68% of float, while stock slides 31.2% in same period.
- Market cap
- $145M
- Next earnings
- 13 Nov 2026
Key data as of 12 Nov 2026

Latest signals on ARMP
- Short Interest
ARMP short interest dips 26.7% over one week to 0.68% of float, while stock slides 31.2% in same period.
ARMP news and analysis
RSSNo long-form analysis yet for ARMP. Pulse alerts and the live data picture are available on ORTEX.
Open ARMP on ORTEX →Want the live picture for ARMP?
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for ARMP — free to start on ORTEX.
Sign up for free →Open ARMP on ORTEX